Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01 - No Clinical Trial Allowed)

This Funding Opportunity Announcement (FOA) is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research.

The overall goal of this FOA and the companion FOA, RFA-CA-19-012, is to establish a network of collaborating investigators to identify and

credit:


advance research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications.

Specifically, this FOA targets the following area designated as a scientific priority by the Blue Ribbon Panel (BRP):
Recommendation (B) that calls for the establishment of a pediatric immunotherapy translation science network.

The network was envisioned by the BRP as focusing on identifying new targets for immunotherapies, developing new pediatric immunotherapy treatment approaches (e.g., cancer vaccines, cellular therapy, combinations of immunotherapy agents, and others), and defining the biological mechanisms by which pediatric tumors evade the immune system.

This FOA solicits U01 applications for discrete research projects that address relevant research opportunities (e.g., mechanisms of immune evasion, model development, validation of a single target, etc.), whereas the companion FOA, RFA-CA-19-003, solicits multi-component U54 Center applications.

Successful applicants from both FOAs will become members of the Pediatric Immunotherapy Discovery and Development Network (PI-DDN), which will address and implement the BRP recommendations.
Related Programs

21st Century Cures Act - Beau Biden Cancer Moonshot

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: National Institutes of Health

Estimated Funding: $3,000,000



Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-004.html

Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.



Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-004.html

Contact:


Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Agency Email:


Date Posted:
2018-08-13

Application Due Date:


Archive Date:
2019-01-22



Social Entrepreneurship
Spotlight



Serco Teams Up with Social Enterprise to Deliver Improved Community Healthcare Provision

Serco Teams Up with Social Enterprise to Deliver Improved Community Healthcare Provision
Serco, in an agreement with social enterprise Bromley Healthcare, partner together in bids for community services...



Nonprofit Jobs in District of Col

  Social Work Jobs
  Executive Director Jobs
  Executive Director Jobs
  Social Work Jobs
  Foundation Related Jobs





More Federal Domestic Assistance Programs


U.S. Geological Survey Research and Data Collection | National Health Service Corps | National Institutes of Health Acquired Immunodeficiency Syndrome Research Loan Repayment Program | Investing in People in The Middle East and North Africa | Crisis Counseling |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2019 Copyright Michael Saunders